GRAIL, Inc. (GRAL) Business Segments — Operating expenses—Research and development — Quarterly & Annual

Screener

Similar metrics at other companies

MNTSReportable Segment — Research and development expenses

$4.17M+118%

POWLReportable Segment — Research and development expenses

$4.29M+56.2%

EOSEReportable Segment — Research and development expenses

$10.51M+45.9%

AVTXReportable Segment — Research and development expense

$23.42M+66.4%

CSL

CSLReportable Segments — Research and development expenses

$11.78M+33.1%

LNTHReportable — Research And Development Expense

$38.2M-16.0%

Other financials

Income statement

Revenue$44.7M+25.7%

Operating income-$173.8M-9.4%

Net income-$110.2M+3.3%

EPS (diluted)-$2.56+19.5%

Balance sheet

Cash & equivalents$62.6M-52.1%

Total debt$91.3M+46.9%

Total equity$2.5B+9.9%

Total assets$2.8B+5.2%

Cash flow

Operating cash flow-$80.7M-4.9%

CapEx$432.0K+17.1%

Free cash flow-$81.2M-4.9%

Valuation

Market cap$2.72B+129%

Enterprise value$2.75B+145%

P/S16.5×+7.6×

Profitability

Operating margin-338.4%-74.4pp

Net margin-236.9%-52.1pp

FCF margin-179.2%-46.7pp

Returns & leverage

Return on equity-16.1%-1.3pp

Debt / equity0×0.0×

Current ratio10.9×+1.7×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: GRAIL, Inc.’s 10-Q, filed August 6, 2026.

Filed: Aug 6, 2026, 4:11 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001628280-26-054307

(in thousands)	Three Months Ended / June 30,2026	Three Months Ended / June 30,2025	Six Months Ended / June 30,2026	Six Months Ended / June 30,2025
Costs and operating expenses:
Cost of screening revenue (exclusive of amortization of intangible assets) (1)	23,347	19,346	44,591	36,469
Cost of development services revenue (1)	434	501	810	1,672
Research and development	42,463	42,169	84,949	90,609
Sales and marketing	33,121	24,672	59,652	55,494
General and administrative	37,810	28,707	70,241	63,467
Depreciation and intangible assets amortization	36,964	37,252	74,186	74,931
Stock-based compensation	18,908	13,751	35,168	29,200

Item 1. Financial Statements

FAQ

What is GRAIL, Inc.'s business segments — operating expenses—research and development?: GRAIL, Inc. (GRAL) reported business segments — operating expenses—research and development of $42.46M in Q2 2026.
What does business segments — operating expenses—research and development mean?: This metric represents the total costs incurred by a specific business segment for research and development activities, including clinical trials, pilot studies, and product innovation. It reflects the company's investment in advancing its technological pipeline and scientific capabilities. Monitoring this spend helps investors assess the company's commitment to long-term growth and the sustainability of its product development lifecycle.

Ask your AI about GRAIL, Inc.'s business segments — operating expenses—research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk